Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- What is the Stock Market's Achilles Heel?
- 3 Dividend Stocks at Reasonable Prices
- RTI: Are You Doing the Elon Musk Trade?
- Buy These ETFs to Profit from "Sector Rotation"
- Oil & Gas Industry Stock Outlook - May 2013
- Uncharted Territory
- 4 Ways to Short Oil with ETFs
- Options Strategies & the Zacks Rank
- This Week's Growth & Income Stocks
- AWS 5/17: The Fed: The Only Game in Town
- PFP 5/17: The ONLY Investment Story
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/17/2013
| Company Name | Symbol | %Change |
|---|---|---|
| VIASAT INC | VSAT | 19.35% |
| OLD SECOND B | OSBC | 5.76% |
| GAMCO INVEST | GBL | 4.61% |
| CORNING INC | GLW | 4.47% |
| SYNCHRONOSS | SNCR | 4.23% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Shares of IPHS are hitting 52-week highs, but this Zacks #1 Rank (Strong Buy) still has solid valuations.
Company Description
Innophos is a specialty chemical company that produces phosphate products for food, beverage, pharmaceutical, oral care and industrial applications.
Valuations
Shares of IPHS are trading at just 12 times this year's Zacks Consensus Estimate and only 10 times forecasts for 2011. Innophos's price to book is about 2.3. The company has a price to sales of 1.1, which is pretty solid for its industry.
Estimates Rising
Earnings forecasts for Innophos are on the rise over the past few months. The full-year Zacks Consensus Estimate for 2010 is up 28 cents, to $2.84 since the last quarterly report.
Next year's projections are up 43 cents on average, to $3.36. While earnings are expected to dip about 9% this year, that is not a foregone conclusion considering Innophos reported a 31 cent earnings surprise within the past year.
That being said, if this year's estimate is the actual earnings number, next year's growth rate is expected to be almost 19%.
Increasing Demand
In the latest quarterly report, which resulted in the eighth earnings surprise in the past 9 quarters, the company said it sees "strong ongoing year over year volume growth for specialty phosphates".
We will find out if that trend is in fact continuing in the company's upcoming earnings report, scheduled for Nov 2 after the market closes.
The Chart
IPHS is hitting 52-week highs in anticipation of that upcoming announcement, but investors are confident that the company will deliver. The solid valuations and 2% dividend don't hurt either.
Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Growth Trader service
Read the full Snapshot Report on IPHS